AIRS Medical's SwiftMR® Receives FDA Clearance to Work in Conjunction with OEM Deep Learning Reconstruction Solutions - PR Newswire UK
On April 15, 2026, AIRS Medical's SwiftMR® obtained FDA clearance to function alongside OEM deep learning reconstruction solutions, representing a significant regulatory milestone for AI-enhanced medical imaging integration.
